Citation Impact
Citing Papers
Humanized Foxp2 accelerates learning by enhancing transitions from declarative to procedural performance
2014 StandoutNobel
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
2013 Standout
Ocular Hypotensive Effects of an Intratracheally Delivered Liposomal Δ9-Tetrahydrocannabinol Preparation in Rats
2006
Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway
2002
The endocannabinoid system in chronic liver disease
2005
Endocannabinoids potently protect the newborn brain against AMPA‐kainate receptor‐mediated excitotoxic damage
2006
Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions
2003
Memory Reconsolidation and Extinction Have Distinct Temporal and Biochemical Signatures
2004
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
Arachidonylethanolamide Induces Apoptosis of Human Glioma Cells through Vanilloid Receptor-1
2004
The gastrointestinal pharmacology of cannabinoids: an update
2004
Cannabinoid CB1 Receptor Mediates Fear Extinction via Habituation-Like Processes
2006
Role of the endocannabinoid system in Alzheimer's disease: New perspectives
2004
Supply and demand for endocannabinoids
2011
Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142
2009
Receptor-independent actions of cannabinoids on cell membranes: Focus on endocannabinoids
2006
Understanding Synapses: Past, Present, and Future
2008 StandoutNobel
Neurons in medial prefrontal cortex signal memory for fear extinction
2002 Nature
Cannabinoid physiology and pharmacology: 30 years of progress
2004
Gene-Targeting Technologies for the Study of Neurological Disorders
2004
Microglia: active sensor and versatile effector cells in the normal and pathologic brain
2007 Standout
Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation
2005
UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders
2005
The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction
2006
Pharmacological Actions of Cannabinoids
2005
Involvement of Protein Kinase A in Cannabinoid Receptor-Mediated Protection from Oxidative Neuronal Injury
2005
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
2003
The safety of cannabinoids for the treatment of multiple sclerosis
2005
Adverse Health Effects of Marijuana Use
2014 Standout
A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders
2005
Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats
2006
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
Endocannabinoid-Mediated Long-Term Plasticity Requires cAMP/PKA Signaling and RIM1α
2007 StandoutNobel
The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids
2005
Disruption of Endocannabinoid Release and Striatal Long-Term Depression by Postsynaptic Blockade of Endocannabinoid Membrane Transport
2004
Huntington's disease
2007 Standout
Pharmacophores for Ligand Recognition and Activation / Inactivation of the Cannabinoid Receptors
2003
Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia
2006
The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract
2005
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease
2008
Schizophrenia
2009 Standout
Presynaptic plasticity: targeted control of inhibitory networks
2009
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
2010
Mechanism of Carbamate Inactivation of FAAH: Implications for the Design of Covalent Inhibitors and In Vivo Functional Probes for Enzymes
2005
The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus
2006
Cannabinoid signaling in glial cells
2004
Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: Sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla
2005
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
Dopamine Modulation of State-Dependent Endocannabinoid Release and Long-Term Depression in the Striatum
2005
A cell-based screen for drugs to treat Huntington's disease
2004
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
2004 StandoutNature
Effects on Cell Viability
2005
RIM1α and RIM1β Are Synthesized from Distinct Promoters of theRIM1Gene to Mediate Differential But Overlapping Synaptic Functions
2008 StandoutNobel
Cellular and molecular connections between sleep and synaptic plasticity
2003
Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation
2005
SynCAM 1 Adhesion Dynamically Regulates Synapse Number and Impacts Plasticity and Learning
2010 StandoutNobel
Endocannabinoid‐mediated short‐term synaptic plasticity: depolarization‐induced suppression of inhibition (DSI) and depolarization‐induced suppression of excitation (DSE)
2004
Inverse agonism and neutral antagonism at cannabinoid CB1 receptors
2004
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease
2005
The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders
2003
Circuitry for Associative Plasticity in the Amygdala Involves Endocannabinoid Signaling
2004
Locomotor networks are targets of modulation by sensory transient receptor potential vanilloid 1 and transient receptor potential melastatin 8 channels
2009 StandoutNobel
Long-term plasticity at inhibitory synapses
2011
Fatty Acid Amide Hydrolase Controls Mouse Intestinal Motility In Vivo
2005
Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis
2005
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
Cannabinoid-based drugs as anti-inflammatory therapeutics
2005
Review article: endocannabinoids and their receptors in the enteric nervous system
2005
Contributions of the Amygdala to Emotion Processing: From Animal Models to Human Behavior
2005 Standout
ELKS2α/CAST Deletion Selectively Increases Neurotransmitter Release at Inhibitory Synapses
2009 StandoutNobel
Oleamide: a member of the endocannabinoid family?
2004
The Presynaptic Active Zone
2012 StandoutNobel
Elevation of Endocannabinoid Levels in the Ventrolateral Periaqueductal Grey through Inhibition of Fatty Acid Amide Hydrolase Affects Descending Nociceptive Pathways via Both Cannabinoid Receptor Type 1 and Transient Receptor Potential Vanilloid Type-1 Receptors
2006
Effect of Sublingual Application of Cannabinoids on Intraocular Pressure: A Pilot Study
2006
Retrograde Signalling by Endocannabinoids
2005
The endocannabinoid system and its therapeutic exploitation
2004
Enhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear
2004
The Endocannabinoid System Promotes Astroglial Differentiation by Acting on Neural Progenitor Cells
2006
Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia
2004
Synergistic Interactions between Cannabinoids and Environmental Stress in the Activation of the Central Amygdala
2004
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids
2002
Cannabinoids and glaucoma
2004
Synaptotagmin-12 Phosphorylation by cAMP-Dependent Protein Kinase Is Essential for Hippocampal Mossy Fiber LTP
2013 StandoutNobel
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon
2004
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
2013 StandoutNobel
Dual Modulation of Endocannabinoid Transport and Fatty Acid Amide Hydrolase Protects against Excitotoxicity
2005
Cannabinoid CB1 receptors control conditioned drug seeking
2005
Cannabinoids and Multiple Sclerosis
2007
Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid
2004
The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells
2006
Heterosynaptic LTD of Hippocampal GABAergic Synapses
2003
Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P
2006
Endocannabinoid-Mediated Metaplasticity in the Hippocampus
2004
Cannabis, the mind and society: the hash realities
2007
Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium
2006
Neuroprotective effect of cannabidiol, a non‐psychoactive component fromCannabis sativa, on β‐amyloid‐induced toxicity in PC12 cells
2004
TRPV1 structures in distinct conformations reveal activation mechanisms
2013 StandoutNatureNobel
Stress and the brain: from adaptation to disease
2005 Standout
Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors
2004
The endogenous cannabinoid system and its role in nociceptive behavior
2004
Cannabinoids and neuroprotection in CNS inflammatory disease
2005
Distinct Neuronal Coding Schemes in Memory Revealed by Selective Erasure of Fast Synchronous Synaptic Transmission
2012 StandoutNobel
Presynaptic Modulation by Endocannabinoids
2007
Behavioral and Neural Analysis of Extinction
2002
Two Coincidence Detectors for Spike Timing-Dependent Plasticity in Somatosensory Cortex
2006
Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the rat
2004
Cannabinoid 1 (CB1) receptors coupled to cholinergic motorneurones inhibit neurogenic circular muscle contractility in the human colon
2006
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
2007 Standout
CB1 Receptor Knockout Mice Display Reduced Ethanol-Induced Conditioned Place Preference and Increased Striatal Dopamine D2 Receptors
2004
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells
2007
Efficacy and safety of medical cannabinoids in older subjects: A systematic review
2014
Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know
2012
History of Cannabis and Its Preparations in Saga, Science, and Sobriquet
2007
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
2008 Standout
A dual-Ca2+-sensor model for neurotransmitter release in a central synapse
2007 StandoutNatureNobel
Cannabinoids and the Digestive Tract
2005
Disruption of CB1 receptor signaling impairs extinction of spatial memory in mice
2004
The endocannabinoid 2-AG protects the blood–brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines
2005
THE ENDOCANNABINOID SYSTEM: PHYSIOLOGY AND PHARMACOLOGY
2004
LTP and LTD
2004 Standout
The molecular logic of endocannabinoid signalling
2003 Standout
Endocannabinoid Signaling Negatively Modulates Stress-Induced Activation of the Hypothalamic-Pituitary-Adrenal Axis
2004
Inhibition of Fatty-Acid Amide Hydrolase Accelerates Acquisition and Extinction Rates in a Spatial Memory Task
2006
Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes
2006
On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures
2004
Endovanilloids
2004
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
2007 Standout
The probability of neurotransmitter release: variability and feedback control at single synapses
2009
Strength through Diversity
2008
Cannabis-Associated Psychosis
2004
The Biosynthesis, Fate and Pharmacological Properties of Endocannabinoids
2005
Dopaminergic Modulation of Endocannabinoid-Mediated Plasticity at GABAergic Synapses in the Prefrontal Cortex
2010
Cocaine- and Amphetamine-Related Transcript Is Involved in the Orexigenic Effect of Endogenous Anandamide
2005
RIM Proteins Activate Vesicle Priming by Reversing Autoinhibitory Homodimerization of Munc13
2011 StandoutNobel
Endocannabinoid-Mediated Control of Synaptic Transmission
2009
Role of endocannabinoid system in mental diseases
2004
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis
2003
Depolarization‐induced suppression of excitation in murine autaptic hippocampal neurones
2005
The endocannabinoid signalling system: Biochemical aspects
2005
The endocannabinoid system in obesity and type 2 diabetes
2008
Definition of Estrogen Receptor Pathway Critical for Estrogen Positive Feedback to Gonadotropin-Releasing Hormone Neurons and Fertility
2006
Endocannabinoids in the regulation of appetite and body weight
2005
Sulfur(VI) Fluoride Exchange (SuFEx): Another Good Reaction for Click Chemistry
2014 StandoutNobel
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice
2005
Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?
2005
Cannabinoid receptors in atherosclerosis
2006
Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery
2005
A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation
2002
Endocannabinoid system and stress and anxiety responses
2005
Effects of Cannabinoids on Neurotransmission
2005
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Neocortical LTD via Coincident Activation of Presynaptic NMDA and Cannabinoid Receptors
2003
Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
2009
Downregulation of Endocannabinoid Signaling in the Hippocampus Following Chronic Unpredictable Stress
2004
Effect of low doses of ?9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats
2004
Inhibitors of fatty acid amide hydrolase reduce carrageenan‐induced hind paw inflammation in pentobarbital‐treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors
2005
Human Studies of Cannabinoids and Medicinal Cannabis
2005
Emotional Perseveration: An Update on Prefrontal-Amygdala Interactions in Fear Extinction
2004
Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores
2005
Emerging roles for endocannabinoids in long‐term synaptic plasticity
2003
Cannabinoid and cannabinoid‐like receptors in microglia, astrocytes, and astrocytomas
2010
Neuroprotective Effect of(−)Δ9-Tetrahydrocannabinol and Cannabidiol in N-Methyl-d-Aspartate-Induced Retinal Neurotoxicity
2003
Activation of the Cannabinoid Receptor Type 1 Decreases Glutamatergic and GABAergic Synaptic Transmission in the Lateral Amygdala of the Mouse
2003
The endocannabinoid system drives neural progenitor proliferation
2005
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
2010
The therapeutic potential of the cannabinoids in neuroprotection
2002
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
2005
Nitric oxide-induced mitochondrial dysfunction: implications for neurodegeneration
2003
Activation of the endocannabinoid system as a therapeutic approach in a murine model of multiple sclerosis
2005
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Endocannabinoids and Their Implications for Epilepsy
2004
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview
2012
The effects of cannabinoids on contextual conditioned fear in CB1 knockout and CD1 mice
2006
Endocannabinoid Signaling and Long-Term Synaptic Plasticity
2009
A Critical Role for the Cannabinoid CB1Receptors in Alcohol Dependence and Stress-Stimulated Ethanol Drinking
2003
P2X7receptors control 2-arachidonoylglycerol production by microglial cells
2004
Mediation of Amphetamine-Induced Long-Term Depression of Synaptic Transmission by CB1Cannabinoid Receptors in the Rat Amygdala
2003
Increasing endogenous 2‐arachidonoylglycerol levels counteracts colitis and related systemic inflammation
2011
Structure-Based Design of a FAAH Variant That Discriminates between the N-Acyl Ethanolamine and Taurine Families of Signaling Lipids
2006
Cannabinoids and cancer: potential for colorectal cancer therapy
2005
Functional disassociation of the central and peripheral fatty acid amide signaling systems
2004
Biphasic Effects of Cannabinoids on Acetylcholine Release in the Hippocampus: Site and Mechanism of Action
2003
Endocannabinoid-Dependent Neocortical Layer-5 LTD in the Absence of Postsynaptic Spiking
2004
A FAAH-Regulated Class of N-Acyl Taurines That Activates TRP Ion Channels
2006 StandoutNobel
Functional Tolerance and Blockade of Long-Term Depression at Synapses in the Nucleus Accumbens after Chronic Cannabinoid Exposure
2003
Effects of General Anesthesia on Anandamide Blood Levels in Humans
2006
Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection
2006
About Sleep's Role in Memory
2013 Standout
RIM genes differentially contribute to organizing presynaptic release sites
2012 StandoutNobel
STRUCTURE AND FUNCTION OF FATTY ACID AMIDE HYDROLASE
2005
Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors
2005
Cannabinoids cool the intestine
2004
The Science of Marijuana
2007
Stress Hormone Regulation: Biological Role and Translation into Therapy
2009
Increasing cannabinoid levels by pharmacological and genetic manipulation delays disease progression in SOD1 mice
2006
Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate
2013 StandoutNobel
Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning
2011 StandoutNobel
Pharmacology of cannabinoids.
2004
Inactivation of N-Acyl Phosphatidylethanolamine Phospholipase D Reveals Multiple Mechanisms for the Biosynthesis of Endocannabinoids
2006
Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
2004
Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection
2008
Cannabinoids for Medical Use
2015 Standout
Endocannabinoid modulation of fear responses: learning and state-dependent performance effects
2008
CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS
2005
Differential Expression of Cannabinoid Receptors in the Human Colon: Cannabinoids Promote Epithelial Wound Healing
2005
Cannabinoids as Novel Anti-Inflammatory Drugs
2009
ENDOCANNABINOID-MEDIATED SYNAPTIC PLASTICITY IN THE CNS
2006
Plant, Synthetic, and Endogenous Cannabinoids in Medicine
2005
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain
2003
The Endocannabinoid System and the Brain
2012
Activation of the Peripheral Endocannabinoid System in Human Obesity
2005
RIM1α phosphorylation at serine-413 by protein kinase A is not required for presynaptic long-term plasticity or learning
2008 StandoutNobel
Pharmacological and therapeutic targets for Δ9 tetrahydrocannabinol and cannabidiol
2004
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
2005 Science
Up‐regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation
2006
Physiology of Microglia
2011 Standout
Mouse neurexin-1α deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments
2009 StandoutNobel
Multiple Functions of Endocannabinoid Signaling in the Brain
2012
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation
2004
Works of Heike Hermann being referenced
Involvement of brain‐derived neurotrophic factor in cannabinoid receptor‐dependent protection against excitotoxicity
2004
CB1 Cannabinoid Receptors Modulate Kinase and Phosphatase Activity During Extinction of Conditioned Fear in Mice
2004
Coexpression of the cannabinoid receptor type 1 with the corticotropin-releasing hormone receptor type 1 in distinct regions of the adult mouse forebrain
2004
Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1
2002
The endogenous cannabinoid system controls extinction of aversive memories
2002 Nature
The endogenous cannabinoid system protects against colonic inflammation
2004
CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
2003 Science
The endogenous cannabinoid system protects against colonic inflammation
2004